Related references
Note: Only part of the references are listed.Evaluation of oxidative metabolism and oxidative DNA damage in patients with obsessive-compulsive disorder
Demet Alici et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2016)
Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial
Hamid Emadi-Kouchak et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2016)
Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial
Ali Ghaleiha et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2016)
Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study
Sahra Emamzadehfard et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2016)
DNA damage and antioxidants in treatment naive children with obsessive-compulsive disorder
Seref Simsek et al.
PSYCHIATRY RESEARCH (2016)
Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder: A Pilot Randomized Placebo-Controlled Trial
Christopher Pittenger et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial
M. Shalbafan et al.
PHARMACOPSYCHIATRY (2015)
Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder
Mahnaz Heidari et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive-Compulsive Disorder
Paul J. Grant et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study
Mohammad-Reza Khodaie-Ardakani et al.
PSYCHIATRY RESEARCH (2014)
Obsessive-compulsive disorders
Per Hove Thomsen
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2013)
Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study
Ali Ghaleiha et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)
Mohammad Haghighi et al.
PSYCHOPHARMACOLOGY (2013)
Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder A Randomized, Double-Blind, Placebo-Controlled Trial
Neda Askari et al.
CNS DRUGS (2012)
Minocycline Therapeutic Potential in Psychiatry
Olivia M. Dean et al.
CNS DRUGS (2012)
The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder
Me Wu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse
Marianne Gueldenpfennig et al.
PHYSIOLOGY & BEHAVIOR (2011)
Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment
Christopher Pittenger et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice
Felipe V. Gomes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Clinical predictors of health-related quality of life in obsessive-compulsive disorder
Umberto Albert et al.
COMPREHENSIVE PSYCHIATRY (2010)
Minocycline Augmentation of Pharmacotherapy in Obsessive-Compulsive Disorder: An Open-Label Trial
Carolyn I. Rodriguez et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder
S. Evelyn Stewart et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Effects of agents targeting glutamatergic systems on marble-burying behavior
Michihiko Iijima et al.
NEUROSCIENCE LETTERS (2010)
Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder An Open-Label Trial
Elias Aboujaoude et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive-Compulsive Disorder
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain
Lin Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Neuroprotective agents for clinical trials in ALS - A systematic assessment
B. J. Traynor et al.
NEUROLOGY (2006)
Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines
AY Lai et al.
GLIA (2006)
Treatment-refractory obsessive-compulsive disorder: Methodological issues, operational definitions and therapeutic lines
S Pallanti et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder
DL Lafleur et al.
PSYCHOPHARMACOLOGY (2006)
Glutamatergic dysfunction in OCD
K Chakrabarty et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
V Coric et al.
BIOLOGICAL PSYCHIATRY (2005)
Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage
N Morimoto et al.
BRAIN RESEARCH (2005)
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder
EB Foa et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Reduced anterior cingulate glutarnatergic concentrations in childhood OCD and major depression versus healthy controls
DR Rosenberg et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2004)
Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways
RB Pi et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Neuroprotection by tetracyclines
M Domercq et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Symptom stability in adult obsessive-compulsive disorder: Data from a naturalistic two-year follow-up study
D Mataix-Cols et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder
M Kuloglu et al.
NEUROPSYCHOBIOLOGY (2002)
Clinical predictors of drug response in obsessive-compulsive disorder
S Erzegovesi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Toward a neurobiology of obsessive-compulsive disorder
AM Graybiel et al.
NEURON (2000)
Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine
DR Rosenberg et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2000)
Share Paper
